RESUMO
The authors present the French concept of a mobile neurosurgical unit (MNSU) as used to provide specific support to remote military medicosurgical units deployed in Africa, South America, Central Europe, and Afghanistan. From 2001 to 2009, 15 missions were performed, for 16 patients. All but 3 of these missions (those in Kosovo, French Guyana, and Afghanistan) concerned Africa. Eleven patients were French soldiers, 3 were civilians, and 2 were Djiboutian soldiers. The conditions that MNSUs were requested for included craniocerebral wounds (2 cases), closed head trauma (7 cases), spinal trauma (5 cases), and spontaneous intracranial hemorrhage (2 cases). In 5 of the 16 cases, neurosurgical treatment was provided on site. All French soldiers and 2 civilians were evacuated to France. The MNSU can be deployed for timely treatment when some delay in neurosurgical management is acceptable.
Assuntos
Ambulâncias/organização & administração , Medicina Militar/organização & administração , Neurocirurgia/organização & administração , Transporte de Pacientes/organização & administração , Adulto , Administração de Caso/organização & administração , Pré-Escolar , Traumatismos Craniocerebrais/cirurgia , França , Humanos , Masculino , Medicina Militar/métodos , Neurocirurgia/métodos , Telemedicina/métodos , Telemedicina/organização & administração , Telemedicina/estatística & dados numéricos , Transporte de Pacientes/métodos , GuerraAssuntos
Antagonistas Adrenérgicos beta/efeitos adversos , Doença das Coronárias/tratamento farmacológico , Estenose Coronária/induzido quimicamente , Discotomia , Vértebras Lombares/cirurgia , Isquemia Miocárdica/induzido quimicamente , Idoso , Angioplastia Coronária com Balão/instrumentação , Doença das Coronárias/complicações , Doença das Coronárias/fisiopatologia , Estenose Coronária/fisiopatologia , Estenose Coronária/terapia , Hemodinâmica/efeitos dos fármacos , Humanos , Masculino , Isquemia Miocárdica/fisiopatologia , Isquemia Miocárdica/terapia , Assistência Perioperatória , StentsRESUMO
A case of a patient who was admitted to hospital in Paris, France, in February 2001 with autoimmune haemolytic anaemia, probably due to artemether-lumefantrine therapy, is presented. Such a complication has previously been observed in patients receiving drugs containing aryl-amino-alcohols but never before in a patient receiving lumefantrine and may be associated with the increase in episodes of blackwater fever seen in recent years.